GlassScriptPhysician profile
Fiona Yuen
NPI 1649513599
$6,210.97
in general payments reported to CMS, 2019-2025
38 companies · $2,168 in 2025
The $2,168 reported for 2025 was more than what 78% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $49.44 · 2022: $453 · 2023: $1,729 · 2024: $1,597 · 2025: $2,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,425 · Gift: $59.40 · Education: $10.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,425.10 |
| Gift | $59.40 |
| Education | $10.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,129.43 | 2022-2025 | Evenity, Prolia, Tepezza |
| Novo Nordisk INC | $956.45 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $728.18 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $505.69 | 2023-2025 | Jardiance, Tradjenta |
| Dexcom, INC. | $406.14 | 2023-2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Medtronic, INC. | $310.40 | 2022-2025 | Minimed 780g, Minimed 770g, Na |
| Bayer Healthcare Pharmaceuticals INC. | $278.27 | 2023-2025 | |
| Ascendis Pharma Endocrinology INC | $239.56 | 2025 | Yorvipath |
| Radius Health, INC. | $184.48 | 2022-2024 | Tymlos |
| Exact Sciences Corporation | $158.74 | 2023-2025 | Cologuard Collection Kit |
| Mannkind Corporation | $153.49 | 2022-2025 | Afrezza |
| Sanofi-Aventis U.S. LLC | $134.80 | 2023-2024 | |
| Ibsa Pharma INC. | $116.38 | 2023 | Tirosint |
| Xeris Pharmaceuticals, INC. | $104.51 | 2022-2025 | Gvoke Hypopen |
| Alexion Pharmaceuticals, INC. | $78.35 | 2019 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius Kabi USA, LLC | $57.17 | 2024-2025 | Adalimumab-Aacf, Idacio |
| Merck Sharp & Dohme LLC | $55.61 | 2024-2025 | Capvaxive, Gardasil 9, Gardasil |
| Glaxosmithkline, LLC. | $52.90 | 2023-2024 | Shingrix, Bexsero, Arexvy |
| Astrazeneca Pharmaceuticals LP | $51.10 | 2023-2024 | Airsupra, Farxiga |
| Abbvie INC. | $50.79 | 2024-2025 | |
| Octapharma USA, INC. | $50.41 | 2023-2024 | Octagam Immune Globulin (Human) |
| Ipsen Biopharmaceuticals, INC | $42.30 | 2019-2020 | |
| Corcept Therapeutics | $40.80 | 2019-2020 | |
| Genentech USA, INC. | $38.33 | 2024-2025 | Actemra |
| Aurinia Pharma U.S., INC. | $29.12 | 2023 | Lupkynis |
| Madrigal Pharmaceuticals | $28.30 | 2025 | Rezdiffra |
| E.R. Squibb & Sons, L.L.C. | $26.62 | 2019 | |
| Abbott Laboratories | $23.81 | 2024 | Freestyle Libre 3 |
| Dynavax Technologies Corporation | $21.37 | 2025 | Heplisav-B |
| Tandem Diabetes Care, INC. | $21.31 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Kyowa Kirin, INC. | $20.44 | 2023 | Crysvita |
| Sequel Med Tech, LLC | $18.83 | 2025 | Twiist |
| Antares Pharma, INC. | $18.63 | 2019 | |
| Beta Bionics, INC. | $17.83 | 2023 | Ilet Bionic Pancreas |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.39 | 2023 | Xifaxan |
| Recordati_rare_diseases_inc. | $14.92 | 2024 | Signifor Lar |
| Cequr Corporation | $14.80 | 2023 | Cequr Simplicity |
| Almatica Pharma LLC | $14.32 | 2025 | Teriparatide, Loreev Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fiona Yuen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.